Exenatide for Stress Hyperglycemia

Summary

Exenatide for Stress Hyperglycemia is a clinical trial^[1].

Key Facts

• Exenatide for Stress Hyperglycemia is in the country of France^[2].
• Exenatide for Stress Hyperglycemia's instance of is recorded as clinical trial^[3].
• Exenatide for Stress Hyperglycemia's start time is recorded as +2015-01-31T00:00:00Z^[4].
• Exenatide for Stress Hyperglycemia's end time is recorded as +2015-12-31T00:00:00Z^[5].
• Exenatide for Stress Hyperglycemia's main subject is recorded as hyperglycemia^[6].
• Exenatide for Stress Hyperglycemia's number of participants is recorded as {'unit': '1', 'amount': '+110'}^[7].
• Exenatide for Stress Hyperglycemia's title is recorded as Intravenous Exenatide (Byetta®) Versus Insulin for Perioperative Glycemic Control in Cardiac Surgery: the Open-labeled Randomized Phase II/III ExStress Study^[8].
• Exenatide for Stress Hyperglycemia's short name is recorded as ExSTRESS^[9].
• Exenatide for Stress Hyperglycemia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Exenatide for Stress Hyperglycemia's ClinicalTrials.gov ID is recorded as NCT01969149^[11].
• Exenatide for Stress Hyperglycemia's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+99'}^[12].
• Exenatide for Stress Hyperglycemia's research intervention is recorded as exenatide^[13].
• Exenatide for Stress Hyperglycemia's research intervention is recorded as Insulin Lispro^[14].
• Exenatide for Stress Hyperglycemia's clinical trial phase is recorded as phase II clinical trial^[15].
• Exenatide for Stress Hyperglycemia's clinical trial phase is recorded as phase III clinical trial^[16].
• Exenatide for Stress Hyperglycemia's research subject recruitment status is recorded as completed^[17].
• Exenatide for Stress Hyperglycemia's study type is recorded as interventional study^[18].